We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Marathon Petroleum
MPC
$134B
| $3.59M | 0.39% |
71,062
| – | – |
2016 Q1
4 quarters
|
|
52
Ford
F
$49.1B
| $3.26M | 0.36% |
280,000
| – | – |
2016 Q1
4 quarters
|
|
53
Baxter International
BAX
$13.3B
| $3.11M | 0.34% |
60,000
| – | – |
2016 Q1
4 quarters
|
|
|
PIV
54
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
| $2.74M | 0.3% |
100,000
| – | – |
2016 Q4
1 quarter
|
|
55
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.2B
| $2.48M | 0.27% |
12,000
| – | – |
2016 Q1
4 quarters
|
|
56
Vanguard Dividend Appreciation ETF
VIG
$113B
| $2.43M | 0.27% |
26,988
| – | – |
2016 Q4
1 quarter
|
|
57
Markel Group
MKL
$22.6B
| $2.38M | 0.26% |
2,442
| – | – |
2016 Q1
4 quarters
|
|
58
Teleflex
TFX
$5.43B
| $2.22M | 0.24% |
11,463
+1,739
| +18% | +$313K |
2016 Q1
4 quarters
|
|
59
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $2.1M | 0.23% |
60,000
| – | – |
2016 Q1
4 quarters
|
|
60
DELISTED
Ansys
ANSS
| $2.1M | 0.23% |
19,618
| – | – |
2016 Q1
4 quarters
|
|
61
CDW
CDW
$19.3B
| $1.93M | 0.21% |
33,405
| – | – |
2016 Q1
4 quarters
|
|
62
SEI Investments
SEIC
$12.6B
| $1.67M | 0.18% |
33,047
| – | – |
2016 Q1
4 quarters
|
|
63
Dentsply Sirona
XRAY
$1.76B
| $1.6M | 0.18% |
25,637
| – | – |
2016 Q1
4 quarters
|
|
64
Bio-Rad Laboratories Class A
BIO
$9.75B
| $1.57M | 0.17% |
7,870
| – | – |
2016 Q1
4 quarters
|
|
65
Blackbaud
BLKB
$2.33B
| $1.46M | 0.16% |
19,024
| – | – |
2016 Q1
4 quarters
|
|
66
Affiliated Managers Group
AMG
$9.91B
| $1.45M | 0.16% |
8,841
| – | – |
2016 Q1
4 quarters
|
|
67
Fair Isaac
FICO
$16.6B
| $1.44M | 0.16% |
11,139
| – | – |
2016 Q1
4 quarters
|
|
68
W.R. Berkley
WRB
$27.5B
| $1.43M | 0.16% |
68,411
| – | – |
2016 Q1
4 quarters
|
|
69
Manhattan Associates
MANH
$13.2B
| $1.4M | 0.15% |
26,961
+2,778
| +11% | +$140K |
2016 Q1
4 quarters
|
|
70
IDEX
IEX
$17.4B
| $1.39M | 0.15% |
14,880
| – | – |
2016 Q1
4 quarters
|
|
71
Jack Henry & Associates
JKHY
$11B
| $1.3M | 0.14% |
13,959
| – | – |
2016 Q1
4 quarters
|
|
72
Carlisle Companies
CSL
$13.3B
| $1.29M | 0.14% |
12,126
| – | – |
2016 Q1
4 quarters
|
|
73
JB Hunt Transport Services
JBHT
$22.1B
| $1.29M | 0.14% |
14,064
| – | – |
2016 Q1
4 quarters
|
|
74
Sally Beauty Holdings
SBH
$1.6B
| $1.23M | 0.13% |
59,975
| – | – |
2016 Q1
4 quarters
|
|
75
TSMC
TSM
$2.19T
| $1.2M | 0.13% |
36,432
-1,669
| -4% | -$52.1K |
2016 Q1
4 quarters
|
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.